Veracor Capital

Overview

Veracor Capital is a veteran-owned healthcare investment firm deploying strategic capital into companies that align with their Signal-Based Medicine methodology. Founded by Kenton Gray, a Marine Corps veteran with over 20 years of experience building healthcare solutions, Veracor Capital focuses on investments that prioritize patient outcomes over recurring revenue. Their approach is built on a proven track record: 47,000+ patients helped, 95% success rate, and operations across all 50 states. They invest in companies that share their mission to heal, not just treat. Veracor Capital's investment thesis centers on healthcare solutions that identify and correct biological dysfunction at the cellular level. They prove that investment returns and meaningful impact aren't competing priorities — they're aligned through better patient outcomes. Their portfolio companies don't just treat symptoms; they restore function and create lasting health outcomes. Veracor Capital isn't a fund searching for deals — it's a fund created to scale companies they've already spent 20 years building. The operations came first. The fund came second. They built it before they funded it. Most funds raise capital then search for deals. Veracor Capital spent 20 years building KureCare, EliteMD, Pure Pak, and the clinical infrastructure — then formed a fund to scale what already works. The risk profile is fundamentally different. Revenue today, not promises. KureCare generated $4.6M in 2025. RIIZE did $3.6M in its first year. These aren't pre-revenue bets — they're operating companies being retooled for exponential growth in 2026. Founder-Operator alignment. Kenton Gray built these companies before raising outside capital. 2025 was an intentional build year — retooling RIIZE from prescription to DTC, developing KureOS, and structuring the multi-fund strategy. His track record is the fund's track record.

Investment Focus

• Accredited investors only

Portfolio Companies